How to explain the differences between renin angiotensin system modulators

American Journal of Hypertension

Volumn 18, Issue 9 SUPPL., 2005, Pages 134-141

  Levy, Bernard I ^a  

^a INSERM   (France)

Author keywords

Angiogenesis; Angiotensin; Fibrosis; Hypertrophy; Vasomotricity

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; CANDESARTAN HEXETIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INDAPAMIDE; IRBESARTAN; LOSARTAN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; PERINDOPRIL; QUINAPRIL;

ARTERIAL PRESSURE; BIRTH; BLOOD VESSEL INJURY; BLOOD VESSEL TONE; CELL PROLIFERATION; FETUS; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; INFLAMMATION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SODIUM ABSORPTION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; WOUND HEALING;

EID: 23944519605     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.05.005     Document Type: Article

References (55)

1. S. Verma, M. Strauss Angiotensin receptor blockers and myocardial infarction BMJ 329 2004 1248 1249
2. V.J. Dzau, M. Mukoyama, R.E. Pratt Molecular biology of angiotensin receptors target for drug research? J Hypertens 12 Suppl 1994 S1 S5
3. M. Horiuchi, M. Akishita, V.J. Dzau Recent progress in angiotensin II type 2 receptor research in the cardiovascular system Hypertension 33 1999 613 621
4. H.M. Siragy The role of the AT2 in hypertension Am J Hypertens 13 2000 62S 67S
5. R.M. Carey, X.H. Jin, H.M. Siragy Role of the angiotensin AT2 in blood pressure regulation and therapeutic implications Am J Hypertens 14 2001 98S 102S
6. D.H. Munzenmaier, A.S. Greene Opposing actions of angiotensin II on microvascular growth and arterial blood pressure Hypertension 27 1996 760 765
7. L. Hein, G.S. Barsh, R.E. Pratt, V.J. Dzau, B.K. Kobilka Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice Nature 377 1995 744 747
8. T. Ichiki, P.A. Labosky, C. Shiota, S. Okuyama, Y. Imagawa, A. Fogo, F. Niimura, I. Ichikawa, B.L. Hogan, T. Inagami Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor Nature 377 1995 748 750
9. Y. Tsutsumi, H. Matsubara, H. Masaki, H. Kurihara, S. Murasawa, S. Takai, M. Miyazaki, Y. Nozawa, R. Ozono, K. Nakagawa, T. Miwa, N. Kawada, Y. Mori, Y. Shibasaki, Y. Tanaka, S. Fujiyama, Y. Koyama, A. Fujiyama, H. Takahashi, T. Iwasaka Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation J Clin Invest 104 1999 925 935
10. K. Matrougui, B.I. Levy, D. Henrion Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats Br J Pharmacol 130 2000 521 526
11. R.E. Widdop, K. Matrougui, B.I. Levy, D. Henrion AT2-mediated relaxation is preserved after long-term AT1 receptor blockade Hypertension 40 2002 516 520
12. Q.N. Diep, J.S. Li, E.L. Schiffrin In vivo study of AT1 and AT2 angiotensin receptors in apoptosis in rat blood vessels Hypertension 34 1999 617 624
13. B.I. Levy, J. Benessiano, D. Henrion, L. Caputo, C. Heymes, M. Duriez, P. Poitevin, J.L. Samuel Chronic blockade of AT2 subtype angiotensin II receptors prevents the effect of angiotensin II on the rat vascular structure J Clin Invest 98 1996 418 425
14. Z. Cao, R. Dean, L. Wu, D. Casley, M.E. Cooper Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy Hypertension 34 1999 408 414
15. T. Senbonmatsu, S. Ichihara, E. Price Jr, F.A. Gaffney, T. Inagami Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload J Clin Invest 106 2000 R25 R29
16. S. Ichihara, T. Senbonmatsu, E. Price Jr, T. Ichiki, F.A. Gaffney, T. Inagami Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension Circulation 104 2001 346 351
17. M. Akishita, M. Horiuchi, H. Yamada, L. Zhang, G. Shirakami, K. Tamura, Y. Ouchi, V.J. Dzau Inflammation influences vascular remodeling through AT2 expression and signalling Physiol Genom 2 2000 13 20
18. M. Akishita, M. Iwai, L. Wu, L. Zhang, Y. Ouchi, V.J. Dzau, M. Horiuchi Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodelling after aortic banding in mice Circulation 102 2000 1684 1689
19. S. Otsuka, M. Sugano, N. Makino, S. Sawada, T. Hata, Y. Niho Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats Hypertension 32 1998 467 472
20. M.D. Schneider, B.H. Lorell AT2, judgment day which angiotensin receptor is the culprit in cardiac hypertrophy? Circulation 104; 2001 247 248
21. G. Filippatos, M. Tilak, H. Pinillos, B.D. Uhal Regulation of apoptosis by angiotensin II in the heart and lungs Int J Mol Med 7 2001 273 280
22. G. Gobe, J. Browning, T. Howard, N. Hogg, C. Winterford, R. Cross Apoptosis occurs in endothelial cells during hypertension-induced microvascular rarefaction J Struct Biol 118 1997 63 72
23. N. Kubis, C. Richer, V. Domergue, J.F. Giudicelli, B.I. Levy Role of microvascular rarefaction in the increased arterial pressure in mice lacking the endothelial nitric oxide synthase gene (eNOS3pt-/-) J Hypertens 20 2002 1581 1587
24. I. Goldenberg, E. Grossman, K.A. Jacobson, V. Shneyvays, A. Shainberg Angiotensin II-induced apoptosis in rat cardiomyocyte culture a possible role of AT1 and AT2 J Hypertens 19 2001 1681 1689
25. G. Ding, K. Reddy, A.A. Kapasi, N. Franki, N. Gibbons, B.S. Kasinath, P.C. Singhal Angiotensin II induces apoptosis in rat glomerular epithelial cells Am J Physiol Renal Physiol 283 2002 F173 F180
26. M. Bhaskaran, K. Reddy, N. Radhakrishanan, N. Franki, G. Ding, P.C. Singhal Angiotensin II induces apoptosis in renal proximal tubular cells Am J Physiol Renal Physiol 284 2003 F955 F965
27. T. Yamada, M. Akishita, M.J. Pollman, G.H. Gibbons, V.J. Dzau, M. Horiuchi Angiotensin II type 2 receptor mediates programmed cell death Proc Nat Acad Sci USA 93 1996 156 160
28. E.L. Marchand, S. Der Sarkissian, P. Hamet, D. deBlois Caspase-dependent cell death mediates the early phase of aortic hypertrophy regression in losartan-treated spontaneously hypertensive rats Circ Res 92 2003 777 784
29. H. Sugino, R. Ozono, S. Kurisu, H. Matsuura, M. Ishida, T. Oshima, M. Kambe, Y. Teranishi, H. Masaki, H. Matsubara Apoptosis is not increased in myocardium overexpressing type 2 angiotensin II receptor in transgenic mice Hypertension 37 2001 1394 1398
30. R. Moudgil, S. Musat-Marcu, Y. Xu, D. Kumar, B.I. Jugdutt Increased AT2R protein expression but not increased apoptosis during cardioprotection induced by AT1R blockade Can J Cardiol 18 2002 1107 1116
31. J.L. Bascands, J.P. Girolami, M. Troly, I. Escargueil-Blanc, D. Nazzal, R. Salvayre, N. Blaes Angiotensin II induces phenotype-dependent apoptosis in vascular smooth muscle cells Hypertension 38 2001 1294 1299
32. B.S. Tea, S. Der Sarkissian, R.M. Touyz, P. Hamet, D. deBlois Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo Hypertension 35 2000 1069 1073
33. T. Senbonmatsu, T. Saito, E.J. Landon, O. Watanabe, E. Price Jr, R.L. Roberts, H. Imboden, T.G. Fitzgerald, F.A. Gaffney, T. Inagami A novel angiotensin II type 2 receptor signaling pathway possible role in cardiac hypertrophy EMBO J 22 2003 6471 6482
34. S. Nouet, N. Amzallag, J.M. Li, S. Louis, I. Seitz, T.X. Cui, A.M. Alleaume, M. Di Benedetto, C. Boden, M. Masson, A. Donny Strosberg, M. Horiuchi, P.O. Couraud, C. Nahmias Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP J Biol Chem 279 2004 28989 28997
35. D.E. Richard, E. Berra, J. Pouyssegur Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells J Biol Chem 275 2000 26765 26771
36. J. Katada, M. Muramatsu, I. Hayashi, M. Tsutsumi, Y. Konishi, M. Majima Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas J Pharmacol Exp Ther 302 2002 949 956
37. R. Tamarat, J.S. Silvestre, N. Kubis, J. Benessiano, M. Duriez, M. deGasparo, D. Henrion, B.I. Levy Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb Hypertension 39 2002 830 835
38. S. Fujiyama, H. Matsubara, Y. Nozawa, K. Maruyama, Y. Mori, Y. Tsutsumi, H. Masaki, Y. Uchiyama, Y. Koyama, A. Nose, O. Iba, E. Tateishi, N. Ogata, N. Jyo, S. Higashiyama, T. Iwasaka Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation Circ Res 88 2001 22 29
39. C. Berry, R. Touyz, A.F. Dominiczak, R.C. Webb, D.G. Johns Angiotensin receptors signaling, vascular pathophysiology, and interactions with ceramide Am J Physiol Heart Circ Physiol 281 2001 H2337 H2365
40. J. Du, L.S. Sperling, M.B. Marrero, L. Phillips, P. Delafontaine G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells thrombin- and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate-1 and insulin-like growth factor 1 receptor Biochem Biophys Res Commun 218 1996 934 939
41. M. Stoll, U.M. Steckelings, M. Paul, S.P. Bottari, R. Metzger, T. Unger The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells J Clin Invest 95 1995 651 657
42. D.A. Walsh, D.E. Hu, J. Wharton, J.D. Catravas, D.R. Blake, T.P. Fan Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma Br J Pharmacol 120 1997 1302 1311
43. B.S. Tea, S.D. Sarkissian, R.M. Touyz, P. Hamet, D. DeBlois Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo Hypertension 35 2000 1069 1073
44. J.S. Silvestre, R. Tamarat, T. Senbonmatsu, T. Icchiki, T. Ebrahimian, M. Iglarz, S. Besnard, M. Duriez, T. Inagami, B.I. Levy Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb Circ Res 90 2002 1072 1079
45. M. Nakajima, H.G. Hutchinson, M. Fujinaga, W. Hayashida, R. Morishita, L. Zhang, M. Horiuchi, R.E. Pratt, V.J. Dzau The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor gain-of-function study using gene transfer Proc Natl Acad Sci USA 92 1995 10663 10667
46. P. Gohlke, I. Kuwer, A. Schnell, K. Amann, G. Mall, T. Unger Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats Hypertension 29 1997 478 482
47. J.E. Fabre, A. Rivard, M. Magner, M. Silver, J.M. Isner Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo Circulation 99 1999 3043 3049
48. S. Takeshita, H. Tomiyama, N. Yokoyama, Y. Kawamura, T. Furukawa, Y. Ishigai, T. Shibano, T. Isshiki, T. Sato Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats Cardiovasc Res 52 2001 314 320
49. L. Morbidelli, A. Parenti, L. Giovannelli, H.J. Granger, F. Ledda, M. Ziche B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects Br J Pharmacol 124 1998 1286 1292
50. C. Emanueli, A. Minasi, A. Zacheo, J. Chao, L. Chao, M.B. Salis, S. Straino, M.G. Tozzi, R. Smith, L. Gaspa, G. Bianchini, F. Stillo, M.C. Capogrossi, P. Madeddu Local delivery of human tissue kallikrein gene accelarates spontaneous angiogenesis in mouse model of hindlimb ischemia Circulation 103 2001 125 132
51. J.S. Silvestre, S. Bergaya, R. Tamarat, M. Duriez, C.M. Boulanger, B.I. Lévy Pro-angiogenic effect of angiotensin-converting enzyme is mediated by the bradykinin B2 receptor pathway Circ Res 89 2001 678 683
52. J.S. Silvestre, R. Tamarat, T. Senbonmatsu, T. Icchiki, T. Ebrahimian, M. Iglarz, S. Besnard, M. Duriez, T. Inagami, B.I. Levy Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb Circ Res 90 2002 1072 1079
53. J.E. Fabre, A. Rivard, M. Magner, M. Silver, J.M. Isner Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo Circulation 99 1999 3043 3049
54. J.S. Silvestre, S. Bergaya, R. Tamarat, M. Duriez, C.M. Boulanger, B.I. Levy Proangiogenic effect of angiotensin-converting enzyme is mediated by the bradykinin B2 receptor pathway Circ Res 89 2001 678 683
55. J.S. Silvestre, N. Kamsu-Kom, M. Clergue, M. Duriez, B.I. Levy Very-low dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs J Pharmacol Exp Ther 303 2002 1038 1043